Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bolt Biotherapeutics, Inc.BOLT · Entity 8082 | Director | June 12, 2023 | June 14, 2023 |
| Corvus Pharmaceuticals, Inc.CRVS · Entity 4839 | Director · President and CEO | May 18, 2026 | May 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bolt Biotherapeutics, Inc.
Report date June 12, 2023 · Filed June 14, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.63 · Expires 2033-06-11 | Direct | 25,000 |
Reported balance
After 2023-06-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-06-12 · Grant · Acquired 25,000 · Balance 25,000 F1: The shares subject to the option will vest on the earlier of June 12, 2024 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option will vest on the earlier of June 12, 2024 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer.
Corvus Pharmaceuticals, Inc.
Report date May 18, 2026 · Filed May 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 1,195,035 |
Last balance in matching sequence
After 2026-05-18 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-05-18 · Purchase · Acquired 5,000 · Balance 1,193,103 F1: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Row 2 · 2026-05-18 · Purchase · Acquired 1,932 · Balance 1,195,035 F1: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. |
| Common StockSEC Table I · non-derivative | Direct | 1,136,707 |
Reported balance
Holding disclosure · report date 2026-05-18 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,136,707 |
Filing footnotes · ownership attribution and instrument terms
F1: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 18, 2026 Filed May 20, 2026 20:12 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock | 1,932 | $12.01 | $23,203.32 |
DisclosureSEC source: 0001610717-26-000160 · form4.xml · nonDerivative · entry 2 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 1,195,035 F1 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| May 18, 2026 Filed May 20, 2026 20:12 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock | 5,000 | $12.05 | $60,250.00 |
DisclosureSEC source: 0001610717-26-000160 · form4.xml · nonDerivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 1,193,103 F1 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| December 04, 2025 Filed Dec 8, 2025 21:22 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | GrantStock Option (Right to Buy) · Derivative | 1,000,000 | $0.00 Strike: $8.81 | $0.00 |
DisclosureSEC source: 0001610717-25-000411 · form4.xml · derivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2035-12-04 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/36th of the shares subject to the option in successive, equal monthly installments measured from December 4, 2025, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| May 07, 2025 Filed May 9, 2025 20:09 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | Exercise / conversionWarrant (Right to Buy) · Derivative | 559,073 | Not disclosed Strike: $3.50 | Not disclosed |
DisclosureSEC source: 0001610717-25-000115 · form4.xml · derivative · entry 3 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 559,073 shares Expires 2025-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Issued at no additional consideration to the Reporting Person in connection with their subscription for shares of the Issuer's Common Stock at a price of $1.7312. Read SEC document |
| May 07, 2025 Filed May 9, 2025 20:09 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | Exercise / conversionCommon Stock | 559,073 | $3.50 | $1,956,755.50 |
DisclosureSEC source: 0001610717-25-000115 · form4.xml · nonDerivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,136,707 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2024 Filed Dec 23, 2024 21:38 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | GrantStock Option (Right to Buy) · Derivative | 750,000 | $0.00 Strike: $4.99 | $0.00 |
DisclosureSEC source: 0001610717-24-000550 · form4.xml · derivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750,000 Underlying: Common Stock · 750,000 shares Expires 2034-12-20 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/36th of the shares subject to the option in successive, equal monthly installments measured from December 20, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| May 10, 2024 Filed May 14, 2024 21:02 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | GiftCommon Stock | 302,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-24-000237 · form4.xml · nonDerivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 1,188,103 F1 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| May 06, 2024 Filed May 7, 2024 21:05 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseWarrant (Right to Buy) · Derivative | 559,073 | Not disclosed Strike: $3.50 | Not disclosed |
DisclosureSEC source: 0001610717-24-000231 · form4.xml · derivative · entry 3 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 559,073 Underlying: Common Stock · 559,073 shares Expires 2025-06-30 F2 · price: Issued at no additional consideration to the Reporting Person in connection with their subscription for shares of the Issuer's Common Stock at a price of $1.7312. Read SEC document |
| May 06, 2024 Filed May 7, 2024 21:05 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock | 577,634 | $1.73 | $999,999.98 |
DisclosureSEC source: 0001610717-24-000231 · form4.xml · nonDerivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 577,634 Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 21:09 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | GrantStock Option (Right to Buy) · Derivative | 500,000 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001610717-23-000395 · form4.xml · derivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2033-12-06 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/36th of the shares subject to the option in successive, equal monthly installments measured from December 6, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| June 12, 2023 Filed Jun 14, 2023 21:18 UTC | Bolt Biotherapeutics, Inc. BOLT · Entity 8082 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.63 | $0.00 |
DisclosureSEC source: 0001209191-23-037111 · doc4.xml · derivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2033-06-11 F1 · derivative.exercise_date: The shares subject to the option will vest on the earlier of June 12, 2024 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date; provided, however that the option will vest in full upon a change in control of the Issuer. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:30 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | GrantStock Option (Right to Buy) · Derivative | 800,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001140361-23-015800 · form4.xml · derivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,000 Underlying: Common Stock · 800,000 shares Expires 2033-03-31 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 1/36th of the shares subject to the option in successive, equal monthly installments measured from March 31, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| December 14, 2022 Filed Dec 15, 2022 21:32 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock | 10,000 | $0.78 | $7,812.00 |
DisclosureSEC source: 0001567619-22-021650 · doc1.xml · nonDerivative · entry 2 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,490,119 F4 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.7798 to $0.7899, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 18:20 UTC | Bolt Biotherapeutics, Inc. BOLT · Entity 8082 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.36 | $0.00 |
DisclosureSEC source: 0001209191-22-061591 · doc4.xml · derivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-12-13 F1 · derivative.exercise_date: The shares subject to this option shall be fully vested upon grant date of December 14, 2022. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 21:32 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock | 50,000 | $0.74 | $37,015.00 |
DisclosureSEC source: 0001567619-22-021650 · doc1.xml · nonDerivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,480,119 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.73 to $0.7580, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Includes 35,714 shares previously held directly. F3 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| September 28, 2022 Filed Sep 28, 2022 21:45 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock | 25,000 | $0.76 | $19,070.00 |
DisclosureSEC source: 0001567619-22-017917 · doc1.xml · nonDerivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,394,405 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.7425 to $0.79, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| September 20, 2022 Filed Sep 20, 2022 22:58 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock | 5,000 | $0.82 | $4,075.00 |
DisclosureSEC source: 0001567619-22-017639 · doc1.xml · nonDerivative · entry 3 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,369,405 F1 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| September 20, 2022 Filed Sep 20, 2022 22:58 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock | 2,700 | $0.82 | $2,214.00 |
DisclosureSEC source: 0001567619-22-017639 · doc1.xml · nonDerivative · entry 2 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,364,405 F1 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| September 20, 2022 Filed Sep 20, 2022 22:58 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock | 12,300 | $0.81 | $9,964.23 |
DisclosureSEC source: 0001567619-22-017639 · doc1.xml · nonDerivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,361,705 F1 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| August 11, 2022 Filed Aug 15, 2022 22:40 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | GrantStock Option (Right to Buy) · Derivative | 320,000 | $0.00 Strike: $0.97 | $0.00 |
DisclosureSEC source: 0001567619-22-016298 · doc1.xml · derivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,000 Underlying: Common Stock · 320,000 shares Expires 2032-08-11 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from August 11, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| June 27, 2022 Filed Jun 28, 2022 23:15 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock | 5,000 | $1.00 | $4,984.50 |
DisclosureSEC source: 0001567619-22-013465 · doc1.xml · nonDerivative · entry 2 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,349,405 F1 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| June 24, 2022 Filed Jun 28, 2022 23:15 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock | 5,000 | $1.03 | $5,150.00 |
DisclosureSEC source: 0001567619-22-013465 · doc1.xml · nonDerivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,344,405 F1 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| June 10, 2022 Filed Jun 10, 2022 22:21 UTC | Bolt Biotherapeutics, Inc. BOLT · Entity 8082 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $1.99 | $0.00 |
DisclosureSEC source: 0001209191-22-036083 · doc4.xml · derivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-09 F1 · derivative.exercise_date: The shares subject to this option shall vest on the one-year anniversary of June 10, 2022 (the "Vesting Commencement Date") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the one-year anniversary of the Vesting Commencement Date; provided, however that the option will vest in full upon a change in control of the Issuer. Read SEC document |
| June 06, 2022 Filed Jun 6, 2022 22:43 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock | 890 | $1.01 | $898.90 |
DisclosureSEC source: 0001567619-22-012396 · doc1.xml · nonDerivative · entry 3 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,339,405 F1 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 22:43 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock | 170 | $0.97 | $164.90 |
DisclosureSEC source: 0001567619-22-012396 · doc1.xml · nonDerivative · entry 2 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,338,515 F1 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 22:43 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock | 4,830 | $0.98 | $4,733.40 |
DisclosureSEC source: 0001567619-22-012396 · doc1.xml · nonDerivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,338,345 F1 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| March 31, 2022 Filed Apr 1, 2022 20:18 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock | 15,000 | $1.64 | $24,534.00 |
DisclosureSEC source: 0001567619-22-007839 · doc1.xml · nonDerivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,333,515 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.60 to $1.679, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trus Read SEC document |
| March 24, 2022 Filed Mar 28, 2022 19:19 UTC | Bolt Biotherapeutics, Inc. BOLT · Entity 8082 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $3.03 | $0.00 |
DisclosureSEC source: 0000899243-22-012458 · doc4.xml · derivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-03-23 F1 · derivative.exercise_date: The shares subject to this option shall vest on the one-year anniversary of June 10, 2021 (the "Vesting Commencement Date") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the one-year anniversary of the Vesting Commencement Date; provided, however that the option will vest in full upon a change in control of the Issuer. Read SEC document |
| March 17, 2022 Filed Mar 17, 2022 23:09 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock | 5,000 | $1.59 | $7,950.00 |
DisclosureSEC source: 0001567619-22-007172 · doc1.xml · nonDerivative · entry 2 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,318,515 F2 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trus Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 23:09 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock | 25,000 | $1.47 | $36,650.00 |
DisclosureSEC source: 0001567619-22-007172 · doc1.xml · nonDerivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,313,515 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.4798 to $1.48, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trus Read SEC document |
| September 09, 2021 Filed Sep 13, 2021 21:00 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | GrantStock Option (Right to Buy) · Derivative | 320,000 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001567619-21-017015 · doc1.xml · derivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,000 Underlying: Common Stock · 320,000 shares Expires 2031-09-09 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from September 9, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 01:01 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock | 10,000 | $1.93 | $19,254.00 |
DisclosureSEC source: 0001567619-21-016250 · doc1.xml · nonDerivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,288,515 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.90 to $1.94, inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| May 04, 2021 Filed May 5, 2021 21:01 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock | 35,714 | $2.80 | $99,999.20 |
DisclosureSEC source: 0001567619-21-009124 · doc1.xml · nonDerivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,714 Read SEC document |
| February 17, 2021 Filed Feb 17, 2021 21:44 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock | 100,000 | $3.50 | $350,000.00 |
DisclosureSEC source: 0001567619-21-004271 · doc1.xml · nonDerivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,278,515 F1 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| December 16, 2020 Filed Dec 17, 2020 21:16 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | GrantStock Option (Right to Buy) · Derivative | 320,000 | $0.00 Strike: $4.01 | $0.00 |
DisclosureSEC source: 0001567619-20-021266 · doc1.xml · derivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,000 Underlying: Common Stock · 320,000 shares Expires 2030-12-16 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from December 16, 2020, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 21:14 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | GrantStock Option (Right to Buy) · Derivative | 320,000 | $0.00 Strike: $3.54 | $0.00 |
DisclosureSEC source: 0001567619-19-023146 · doc1.xml · derivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,000 Underlying: Common Stock · 320,000 shares Expires 2029-12-12 F1 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to one-forty eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from December 12, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| November 13, 2019 Filed Nov 14, 2019 21:14 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock | 14,736 | $3.00 | $44,240.42 |
DisclosureSEC source: 0001567619-19-021570 · doc1.xml · nonDerivative · entry 2 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,178,515 F3 · price: The price reported in Column 4 is a weighted price. These Shares were purchased in multiple transactions at prices ranging from $2.9543 to $3.0194 inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the Shares purchased at each separate price within the range set forth in this footnote. F1 · balance_after: A portion of these shares is subject to a right of repurchase held by the Issuer. F2 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| November 12, 2019 Filed Nov 14, 2019 21:14 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock | 272 | $2.90 | $788.80 |
DisclosureSEC source: 0001567619-19-021570 · doc1.xml · nonDerivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,163,779 F1 · balance_after: A portion of these shares is subject to a right of repurchase held by the Issuer. F2 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| August 07, 2019 Filed Aug 8, 2019 20:07 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock, $0.0001 par value | 2,500 | $3.54 | $8,850.00 |
DisclosureSEC source: 0000899243-19-021352 · doc4.xml · nonDerivative · entry 2 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,163,507 F2 · balance_after: A portion of these shares is subject to a right of repurchase held by the Issuer. F3 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 20:07 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock, $0.0001 par value | 5,000 | $3.58 | $17,875.00 |
DisclosureSEC source: 0000899243-19-021352 · doc4.xml · nonDerivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,161,007 F1 · price: The price reported in Column 4 is a weighted price. These Shares were purchased in multiple transactions at prices ranging from $3.55 to $3.60 inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the Shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares is subject to a right of repurchase held by the Issuer. F3 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 20:08 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock, $0.0001 par value | 11,657 | $3.40 | $39,666.44 |
DisclosureSEC source: 0000899243-19-017182 · doc4.xml · nonDerivative · entry 2 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,156,007 F3 · price: The price reported in Column 4 is a weighted price. These Shares were purchased in multiple transactions at prices ranging from $3.34 to $3.48 inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the Shares purchased at each separate price within the range set forth in this footnote. F1 · balance_after: A portion of these shares is subject to a right of repurchase held by the Issuer. F2 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 20:08 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock, $0.0001 par value | 343 | $3.52 | $1,207.36 |
DisclosureSEC source: 0000899243-19-017182 · doc4.xml · nonDerivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,144,350 F1 · balance_after: A portion of these shares is subject to a right of repurchase held by the Issuer. F2 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| June 11, 2019 Filed Jun 11, 2019 20:55 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock, $0.0001 par value | 6,000 | $3.67 | $22,020.00 |
DisclosureSEC source: 0001567619-19-013222 · doc1.xml · nonDerivative · entry 2 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,144,007 F2 · balance_after: A portion of these shares is subject to a right of repurchase held by the Issuer F3 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 20:55 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock, $0.0001 par value | 9,212 | $3.37 | $31,018.65 |
DisclosureSEC source: 0001567619-19-013222 · doc1.xml · nonDerivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,138,007 F1 · price: The price reported in Column 4 is a weighted price. These Shares were purchased in multiple transactions at prices ranging from $3.32 to $3.40 inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the Shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares is subject to a right of repurchase held by the Issuer F3 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| December 27, 2018 Filed Dec 31, 2018 21:16 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock, $0.0001 par value | 20,000 | $3.29 | $65,884.00 |
DisclosureSEC source: 0000899243-18-031989 · doc4.xml · nonDerivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,128,795 F1 · price: The price reported in Column 4 is a weighted price. These Shares were purchased in multiple transactions at prices ranging from $3.29 to $3.2985 inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the Shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: A portion of these shares is subject to a right of repurchase held by the Issuer F3 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| December 20, 2018 Filed Dec 26, 2018 21:05 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock, $0.0001 par value | 5,000 | $4.39 | $21,950.00 |
DisclosureSEC source: 0000899243-18-031696 · doc4.xml · nonDerivative · entry 2 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,108,795 F1 · balance_after: A portion of these shares is subject to a right of repurchase held by the Issuer. F2 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| December 20, 2018 Filed Dec 26, 2018 21:05 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | PurchaseCommon Stock, $0.0001 par value | 5,000 | $4.40 | $22,000.00 |
DisclosureSEC source: 0000899243-18-031696 · doc4.xml · nonDerivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,103,795 F1 · balance_after: A portion of these shares is subject to a right of repurchase held by the Issuer. F2 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| December 12, 2018 Filed Dec 14, 2018 21:07 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0000899243-18-031059 · doc4.xml · derivative · entry 3 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2028-12-12 F3 · derivative.exercise_date: The underlying shares subject to the option vest as to one-forty eighth (1/48th) of the shares in successive, equal monthly installments measured from December 12, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. Read SEC document |
| December 11, 2018 Filed Dec 14, 2018 21:07 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | GiftCommon Stock, $0.0001 par value | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-031059 · doc4.xml · nonDerivative · entry 2 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,098,795 F1 · balance_after: A portion of these shares is subject to a right of repurchase held by the Issuer. F2 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
| December 11, 2018 Filed Dec 14, 2018 21:07 UTC | Corvus Pharmaceuticals, Inc. CRVS · Entity 4839 | GiftCommon Stock, $0.0001 par value | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-031059 · doc4.xml · nonDerivative · entry 1 MILLER RICHARD A MD · CIK 0001031847 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,108,795 F1 · balance_after: A portion of these shares is subject to a right of repurchase held by the Issuer. F2 · ownership.nature: These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.